Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spectral Analysis to Guide Deep Sedoanalgesia in ICU Patients
NCT04026451Withdrawn
- Sponsor
- Universidad de Chile
- Start
- Nov 2019
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Universidad de Chile. Primary endpoint: Plasma concentration of propofol at 48 hours. Planned start Nov 2019; status: withdrawn.
Beyond the preview
Go deeper on NCT04026451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026451.